Prof. Dr. med. Reinhard Berner
Research focus
- (Molecular) epidemiology of invasive bacterial and viral infections in children
- Genetic predisposition to invasive infectious diseases
- Screening and prevention of autoimmune diseases
- Diagnostics and pathogenesis of rare autoinflammatory diseases
Table of contents
Curriculum Vitae
Berner, Reinhard, MD, Professor of Pediatrics |
|
Official position |
Chairman and Director, Department of Pediatrics Chairman, University Center for Rare Diseases (USE) |
Institution |
University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany |
Business address |
Fetscherstrasse 74, 01307 Dresden |
Academic education and degrees
1983-1989 |
Studies in Medicine, Julius-Maximilians-Universitaet Wuerzburg, Germany and University of Caen, France |
1990 |
Medical Doctor, Julius-Maximilians-Universitaet Wuerzburg, Germany |
1989-1991 |
Research Fellow, Institute of Medical Microbiology, Julius-Maximilians-Universitaet Wuerzburg, Germany |
1991-1997 |
Residency in Pediatrics, Albert-Ludwigs-Universitaet Freiburg, Germany |
1997 |
Scholarship, Ludwig-Institute for Cancer Research (ISREC), Lausanne Branch, Epalinges, Switzerland |
2000 |
Postdoctoral lecture qualification (venia legendi) in Pediatrics, Albert-Ludwigs-Universitaet Freiburg, Germany |
Professional career
2003-2011 |
Vice-Chairman and Deputy Director, Centre for Pediatrics and Adolescent Medicine, University Medical Center Freiburg, Germany |
2007-2011 |
Chairman, Division of Pediatric Infectious Diseases, Immunology and Vaccinology, Centre for Pediatrics and Adolescent Medicine, University Medical Center Freiburg, Germany |
2009-2011 |
Board Member, Center for Chronic Immunodeficiency (CCI), University Medical Center Freiburg, Germany |
2010-2011 |
Board Member, Center for Infectious Diseases (ZI), University Medical Center Freiburg, Germany |
Since 2012 |
Chairman and Director, Department of Pediatrics, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany |
Since 2013 |
Chairman, Committee on Infectious Diseases, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany |
Since 2015 |
Chairman, University Center for Rare Diseases (USE), University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany |
Honors, awards and positions
2005-2009 and 2015-2017 |
President and Vice-President German Society for Pediatric Infectious Diseases (DGPI) |
Since 2012 |
Board Member German Society for Pediatrics (DGKJ) |
Since 2012 and Since 2018 |
Board Member and Vice-President, Saxonian-Thuringian Society for Pediatrics (STGKJM) |
2018-2019 |
Board Member German Society for Pediatric Rheumatology (GPR) |
2004-2010 |
Appointed Member Commission on Drug Prescription (BfArM) |
Since 2009 |
Appointed Member Commission on Drugs in Children - KAKJ (BfArM) |
2006-2012 |
Appointed Member Commission on Influenza Pandemics (RKI) |
Since 2020 |
Appointed Member Scientific Advisory Board Modelling COVID-19 Vaccine - ImVaCov (RKI) |
1999 |
DPC Academy Research Award |
2000 |
Friedrich-Linneweh-Award (DGKJ) |
2000 |
Research Award (DGPI) |
Current journal editorial positions
Since 2010 |
Associate Editor, Monatsschrift Kinderheilkunde |
Since 2012 |
Associate Editor, Klinische Pädiatrie |
Since 2016 |
Associate Editor Frontiers Pediatrics |
10 most important peer-reviewed papers
(10 out of 217, Scopus h-index: 34)
Berner R. Group B streptococcus vaccines: one step further. Lancet Infect Dis. 2020;S1473-3099(20)30451-5.
Zürn K, Lander F, Hufnagel M, Monecke S, Berner R. Microarray Analysis of Group B Streptococci Causing Invasive Neonatal Early- and Late-onset Infection. Pediatr Infect Dis J. 2020;39(5):449-453.
Armann JP, Diffloth N, Simon A, Doenhardt M, Hufnagel M … Berner R. Hospital Admission in Children and Adolescents With COVID-19. Dtsch Arztebl Int. 2020;117(21):373-374.
Ziegler AG, Achenbach P, Berner R, Casteels K, Danne T et al. Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol. BMJ Open. 2019;9(6):e028578.
Ziegler AG, Hoffmann GF, Hasford J, Larsson HE, Danne T, Berner R et al. Screening for asymptomatic β-cell autoimmunity in young children. Lancet Child Adolesc Health. 2019;pii:S2352-4642(19)30028-8.
Toepfner N, Herold C, Otto O, Rosendahl P, Jacobi A … Berner R et al. Detection of human disease conditions by single-cell morpho-rheological phenotyping of blood. Elife. 2018;7pii:e29213.
Moghaddas F, Zeng P, Zhang Y, Schützle H, Brenner S … Berner R et al. Autoinflammatory mutation in NLRC4 reveals a leucine-rich repeat (LRR)-LRR oligomerization interface. J Allergy Clin Immunol. 2018;142(6):1956-1967.
Belard S, Toepfner N, Capan-Melser M, Mombo-Ngoma G, Zoleko-Manego R … Berner R. Streptococcus agalactiae serotype distribution and antimicrobial susceptibility in pregnant women in Gabon, Central Africa. Sci Rep. 2015;5:17281.
Da Cunha V, Davies MR, Douarre PE, Rosinski-Chupin I, Margarit I … Berner R et al. Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline. Nat Commun. 2014;5:4544.
Kruetzmann S, Rosado MM, Weber H, Germing U, Tournilac O … Berner R et al. Human IgM memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J Exp Med. 2003;197:939-945.